ConditionPostpartum BluesPostpartum DepressionPostpartum Psychosis
Prevalence40%-80%8%-15%0.1%-0.2%
Onset2-3 days (resolves within 14 days) cTypically within 4-6 weeks (can be up to 1 year)Days to weeks
SymptomsMild depression, tearfulness, irritability≥2 weeks c of moderate to severe depression, sleep or appetite disturbance, low energy, psychomotor changes, guilt, concentration difficulty, suicidal ideationDelusions, hallucinations, thought disorganization, bizarre behavior

Epidemiology


Etiology


Pathophysiology


<% tp.file.cursor() %>

Clinical features


<% tp.file.cursor() %>

Diagnostics


<% tp.file.cursor() %>

Treatment


<% tp.file.cursor() %>

Postpartum psychosis

  • Risk Factors: Bipolar disorder (strongest risk factor; up to 50% recurrence), personal/family history of psychosis, primiparity; typical onset within first 1–2 weeks postpartum.
  • Clinical Presentation:
    • Bizarre delusions centered on the baby (e.g., infant is demonic, possessed, dead, or not theirs).
    • Command auditory hallucinations to harm self or infant.
    • Waxing/waning sensorium (confusion, cognitive disorganization, delirium-like picture), extreme insomnia, and severe mood lability.
  • Workup: Clinical diagnosis; rule out organic mimics with TSH, CBC, CMP, and urine toxicology.
  • Key Differentials:
    • Postpartum blues: Onset days 2–3, resolves spontaneously within <14 days; no psychosis; functioning intact.
    • Postpartum depression: Onset within 4–6 weeks; typical SIGECAPS; lacks overt psychosis or bizarre infant-related delusions.
  • Immediate Management:
    • Emergency psychiatric hospitalization (voluntary or involuntary). c
      • regardless of whether explicit suicidal ideation (SI) is present
    • Safety priority: Do not leave the mother alone with the infant under any circumstances.
  • Pharmacotherapy:
    • First-line: Second-generation antipsychotics (SGAs) (e.g., olanzapine, quetiapine, risperidone) + mood stabilizer (e.g., Lithium).
    • Avoid antidepressant monotherapy (triggers mania/worsens psychosis).
    • Benzodiazepines as needed for acute agitation and severe insomnia.
  • Refractory / Severe Cases: Electroconvulsive therapy (ECT) (treatment of choice for catatonia, severe suicidality, medication refusal, or refractory disease; safe postpartum).
  • Complications & Follow-up:
    • High rate of infanticide (up to 4%) and maternal suicide (up to 5%).
    • High recurrence risk (>50%) requiring prophylactic mood stabilizers immediately after future deliveries.